Lubna Zuberi is an Endocrinology/Metabolic physician affiliated with Thomas Jefferson University. OpenAlex indexes 18 publications with 410 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
211 S 9th St Ste 600
Philadelphia, PA 191076810
Telephone
215-955-1925Registry record last updated 11 Nov 2019.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20253 payments
- AtriCure, Inc.Program year20251 payment
- Novo Nordisk IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
73.1%GLP-1 receptor agonist27.7%Ozempic43%Trulicity43%Mounjaro10%Rybelsus3%Part D<11 patientsInsulin Analog19.6%Lantus Solostar37%Novolog Flexpen17%Humalog Kwikpen U-10012%Tresiba Flextouch U-1007%Tresiba Flextouch U-2007%Insulin Lispro Kwikpen U-1006%Basaglar Kwikpen U-1005%Fiasp Flextouch4%Novolog3%Levemir Flexpen2%Part D<11 patients+ 10 more classes in this area
Hormonal (systemic)
18%l-Thyroxine12.9%Levothyroxine Sodium79%Synthroid21%Part D≥96 patientsThyroid Hormone Synthesis Inhibitor2.7%Methimazole100%Part D≥19 patients+ 4 more classes in this area
Cardiovascular
6.2%Statin3.9%Atorvastatin Calcium58%Rosuvastatin Calcium42%Part D≥23 patientsAngiotensin receptor blocker (ARB)0.8%Losartan Potassium100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Abstract #1171626: Parathyroid Carcinoma: A Rare Cause of Primary Hyperparathyroidism
Endocrine Practice
2022 - Vitamin D Deficiency in ambulatory patients.
PubMed
2008 - Vitamin B12 deficiency common in primary hypothyroidism.
PubMed
2008
Similar KOLs
Other experts from the same institution or the same specialty.
Carol Shields, MD
Thomas Jefferson University
Joseph Bavaria, MD
Thomas Jefferson University
Michele Meltzer, MD
Thomas Jefferson University
Marinos Dalakas, MD
Thomas Jefferson University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”